Medifast, Inc. Earnings Recaps
Q1 2026
May 5, 2026
Shares rose 19.3% as the market rewarded Medifast for its initial signs of stabilization and sequential quarterly revenue growth after three years of decline, driven by solid coach productivity gains and progress in repositioning toward metabolic health.
Key takeaways
- First quarter marked the first sequential quarterly revenue growth in three years, signaling a potential turnaround after an extended downturn.
- The number of active earning coaches continues to decline but was offset by a second consecutive quarter of year-over-year coach productivity improvements.
- Enhanced coach leadership and a higher percentage of coaches acquiring new clients indicate strengthening field engagement.
- The company has realigned its cost structure, targeting over $30 million of future savings to support reattaining profitability despite ongoing investments in long-term growth.
- Medifast is advancing its metabolic synchronization science, with new clinically backed products planned for rollout later this year, aiming to further differentiate in the shifting weight loss and metabolic health market.
Q3 2025
Nov 4, 2025
Medifast's third-quarter results for 2025 showcased a strategic shift towards a holistic approach to metabolic health, reinforcing its commitment to long-term wellness solutions while navigating changes in the weight loss industry.
Key takeaways
- Achieved 16-week clinical results showing clients retained 98% of lean mass and reduced visceral fat by 14%, underscoring the effectiveness of its metabolic health programs.
- Expanded insights with 61% of coaches assisting clients using GLP-1 medications, highlighting the integration of medication knowledge into client support.
- Announced plans for innovative product launches incorporating next-generation ingredients targeting metabolic enhancement, set to hit the market next year.
- Transitioning brand perception from a weight loss company to a broader leader in metabolic health, targeting a more expansive and durable market.